Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125232971 | 12523297 | 1 | I | 20160613 | 20160624 | 20160702 | 20160702 | EXP | IT-AMGEN-ITASP2016084374 | AMGEN | 74.00 | YR | E | F | Y | 60.00000 | KG | 20160702 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125232971 | 12523297 | 1 | PS | PROLIA | DENOSUMAB | 1 | Intramuscular | 60 MG, AS NECESSARY | 125320 | 60 | MG | SOLUTION FOR INJECTION | |||||||
| 125232971 | 12523297 | 2 | SS | FOSAVANCE | ALENDRONATE SODIUMCHOLECALCIFEROL | 1 | Oral | 70 MG, QWK | 37800 | MG | 0 | 70 | MG | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125232971 | 12523297 | 1 | Osteoporosis |
| 125232971 | 12523297 | 2 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125232971 | 12523297 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125232971 | 12523297 | Incorrect route of drug administration | |
| 125232971 | 12523297 | Osteonecrosis of jaw |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125232971 | 12523297 | 1 | 20160615 | 0 | ||
| 125232971 | 12523297 | 2 | 20030213 | 20130614 | 0 |